Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14976728 | 0.85 | L3MBTL1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL8010270 | 0.82 | — | — | |
| SCHEMBL29246489 | 0.79 | THRB (0.30) | ALDH1A1TSHR | |
| SCHEMBL1370508 | 0.75 | — | — | |
| SCHEMBL5006941 | 0.75 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL2302184 | 0.75 | — | — | |
| SCHEMBL138469 | 0.75 | — | — | |
| SCHEMBL108911 | 0.75 | — | — | |
| SCHEMBL10453712 | 0.75 | — | — | |
| Bromide SCHEMBL258976 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11772085-B2 | Far superior oxidation catalysts based on macrocyclic compounds | CARNEGIE MELLON UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| WO-2022147214-A2 | CYCLIC-DISULFIDE MODIFIED PHOSPHATE BASED OLIGONUCLEOTIDE PRODRUGS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| EP-4015511-A1 | OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | CARNEGIE MELLON UNIVERSITY (US) | 2022-06-22 | — | — | EP | disclosed |
| EP-3245557-B1 | ELECTROCHROMIC MULTI-LAYER DEVICES WITH CHARGE SEQUESTRATION AND RELATED METHODS | KINESTRAL TECH INC (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3353157-B1 | OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | UNIV CARNEGIE MELLON (US) | 2021-11-24 | — | — | EP | disclosed |
| US-20210086171-A1 | FAR SUPERIOR OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | CARNEGIE MELLON UNIVERSITY | 2021-03-25 | — | — | US | disclosed |
| US-10926248-B2 | Far superior oxidation catalysts based on macrocyclic compounds | CARNEGIE MELLON UNIVERSITY (US) | 2021-02-23 | — | — | US | disclosed |
| CN-107873090-B | Electrochromic multilayer devices using charge trapping and related methods | 基内斯托技术公司 | 2020-07-31 | — | — | CN | disclosed |
| US-10698286-B2 | Electrochromic multi-layer devices with charge sequestration and related methods | KINESTRAL TECHNOLOGIES, INC. (US) | 2020-06-30 | — | — | US | disclosed |
| US-20200048347-A1 | BISPECIFIC ANTIBODIES | IMMUNOMAB, INC. | 2020-02-13 | — | — | US | disclosed |
| EP-0034876-B1 | BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF | PFIZER INC. (US) | 1984-08-29 | — | — | EP | disclosed |
| US-4454328-A | SWEETENERS | PFIZER INC. (US) | 1984-06-12 | — | — | US | disclosed |
| EP-0028430-B1 | A PROCESS FOR THE ELECTROREDUCTIVE PREPARATION OF ORGANIC COMPOUNDS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1984-01-18 | — | — | EP | disclosed |
| US-4411925-A | STABLE SWEETENERS | PFIZER INC. (US) | 1983-10-25 | — | — | US | disclosed |
| US-4399163-A | ARTIFICIAL SWEETENERS | PFIZER INC. (US) | 1983-08-16 | — | — | US | disclosed |
| EP-0069811-A1 | Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof | PFIZER INC. (US) | 1983-01-19 | — | — | EP | disclosed |
| EP-0034876-A2 | Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof | PFIZER INC. (US) | 1981-09-02 | — | — | EP | disclosed |
| EP-0028430-A1 | A process for the electroreductive preparation of organic compounds | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1981-05-13 | — | — | EP | disclosed |
| US-4086251-A | POLYPROPYLENE, POLYBUTYLENE WITH AN ANHYDRIDE | STANDARD OIL COMPANY (INDIANA) (US) | 1978-04-25 | — | — | US | disclosed |
| US-3953475-A | MALEIC ANHYDRIDE | STANDARD OIL COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048347-A1 | BISPECIFIC ANTIBODIES | FCGR3B, CD2BP2, CD22 | ALDH1A1 4136/4885TSHR 2489/4885 |
| US-10926248-B2 | Far superior oxidation catalysts based on macrocyclic compounds | ME3, SOD1, DUOX1 | ALDH1A1 1400/4885TSHR 1297/4885 |
| US-11772085-B2 | Far superior oxidation catalysts based on macrocyclic compounds | SOD1, ME3, ME2 | ALDH1A1 1499/4885TSHR 1480/4885 |
| US-20210086171-A1 | FAR SUPERIOR OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | ME3, ME2, ME1 | ALDH1A1 1801/4885TSHR 1881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.